256 related articles for article (PubMed ID: 28108813)
1. Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.
Si F; Wu Y; Gao F; Feng S; Liu R; Yi Q
Clin Exp Med; 2017 Nov; 17(4):451-457. PubMed ID: 28108813
[TBL] [Abstract][Full Text] [Related]
2. Association between IL-35 and coronary arterial lesions in children with Kawasaki disease.
Su Y; Feng S; Luo L; Liu R; Yi Q
Clin Exp Med; 2019 Feb; 19(1):87-92. PubMed ID: 30054763
[TBL] [Abstract][Full Text] [Related]
3. [Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children].
Zhang XY; He T; Ling JY; Hu XF; Wen Y; Wei J; Lu HL
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):543-548. PubMed ID: 30022755
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease.
Feng S; Su Y; Luo L; Jing F; Yi Q
Pediatr Res; 2018 May; 83(5):999-1003. PubMed ID: 29360808
[TBL] [Abstract][Full Text] [Related]
5. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B
Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
[TBL] [Abstract][Full Text] [Related]
6. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
Li SY; Ding Y
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):244-249. PubMed ID: 36946157
[TBL] [Abstract][Full Text] [Related]
7. Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions.
Feng H; Chai H; Li D; Shi C; Xu Y; Liu Y
Altern Ther Health Med; 2024 Jan; 30(1):302-306. PubMed ID: 37820655
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.
Weng KP; Hsieh KS; Huang SH; Ou SF; Lai TJ; Tang CW; Lin CC; Ho TY; Liou HH; Ger LP
J Chin Med Assoc; 2013 Aug; 76(8):438-45. PubMed ID: 23769880
[TBL] [Abstract][Full Text] [Related]
9. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[TBL] [Abstract][Full Text] [Related]
11. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
Zhang X; Ya-Wang Shao ; Ya-Lan Zhang ; Yi Liu
Heart Surg Forum; 2021 Jul; 24(4):E611-E618. PubMed ID: 34473042
[TBL] [Abstract][Full Text] [Related]
12. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
13. Relationship between adipokines and coronary artery aneurysm in children with Kawasaki disease.
Liu R; He B; Gao F; Liu Q; Yi Q
Transl Res; 2012 Aug; 160(2):131-6. PubMed ID: 22683371
[TBL] [Abstract][Full Text] [Related]
14. Do cytokines correlate with refractory Kawasaki disease in children?
Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
[TBL] [Abstract][Full Text] [Related]
15. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
Wu Y; Wang S; Zhou Y; Yang Y; Li S; Yin W; Ding Y
PLoS One; 2023; 18(10):e0292653. PubMed ID: 37824465
[TBL] [Abstract][Full Text] [Related]
16. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
Chen J; Liu P; Hu W; Xu Y; Deng J
Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of serum soluble TNF receptor II level and soluble TNF receptor II/I ratio as indicators of coronary artery lesion development in Kawasaki disease.
Shimizu M; Mizuta M; Usami M; Inoue N; Sakakibara Y; Yamada K; Konishi M; Ohta K; Yachie A
Cytokine; 2018 Aug; 108():168-172. PubMed ID: 29625336
[TBL] [Abstract][Full Text] [Related]
18. Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
Jin J; Wang J; Lu Y; Fan Z; Huang N; Ma L; Yu H
Indian J Pediatr; 2019 Mar; 86(3):250-255. PubMed ID: 30159809
[TBL] [Abstract][Full Text] [Related]
19. IL-31 associated with coronary artery lesion formation in Kawasaki disease.
Tseng WN; Lo MH; Guo MM; Hsieh KS; Chang WC; Kuo HC
PLoS One; 2014; 9(8):e105195. PubMed ID: 25122210
[TBL] [Abstract][Full Text] [Related]
20. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A; Pal P; Basu S
Rheumatol Int; 2019 Oct; 39(10):1797-1801. PubMed ID: 31302740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]